Home Dental Radiology Use of low-dose naltrexone in the management of chronic pain conditions

Use of low-dose naltrexone in the management of chronic pain conditions

by adminjay


  • Treatment of complex regional pain syndrome (CRPS) using low dose naltrexone (LDN).

    J Neuroimmune Pharmacol. 2013; 8: 470-476

  • Naltrexone: not just for opioids anymore.

    J Med Toxicol. 2016; 12: 71-75

  • Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.

    Am J Drug Alcohol Abuse. 1975; 2: 357-363

    • Younger J.
    • Parkitny L.
    • McLain D.

    The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.

    Clin Rheumatol. 2014; 33: 451-459

  • Bernard Bihari, MD: low-dose naltrexone for normalizing immune system function.

    Altern Ther Health Med. 2013; 19: 56-65

    • Patten D.K.
    • Schultz B.G.
    • Berlau D.J.

    The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn’s disease, and other chronic pain disorders.

    Pharmacotherapy. 2018; 38: 382-389

    • Matsuda M.
    • Huh Y.
    • Ji R.R.

    Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain.

    J Anesth. 2019; 33: 131-139

  • Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.

    Glia. 2010; 58: 253-263

    • Bruno K.
    • Woller S.A.
    • Miller Y.I.
    • et al.

    Targeting toll-like receptor-4 (TLR4)-an emerging therapeutic target for persistent pain states.

    Pain. 2018; 159: 1908-1915

  • Glia in mammalian development and disease.

    Development. 2015; 142: 3805-3809

  • Central Pain Syndrome.

    StatPearls,
    Treasure Island, FL2020

  • Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness.

    Semin Arthritis Rheum. 2008; 37: 339-352

    • Ji R.R.
    • Berta T.
    • Nedergaard M.

    Glia and pain: is chronic pain a gliopathy? Pain. 2013; 154: S10-S28

    • Chen Y.
    • Zhang X.
    • Wang C.
    • Li G.
    • Gu Y.
    • Huang L.Y.

    Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.

    Proc Natl Acad Sci U S A. 2008; 105: 16773-16778

    • Chiang C.Y.
    • Sessle B.J.
    • Dostrovsky J.O.

    Role of astrocytes in pain.

    Neurochem Res. 2012; 37: 2419-2431

    • Chiang C.Y.
    • Wang J.
    • Xie Y.F.
    • et al.

    Astroglial glutamate-glutamine shuttle is involved in central sensitization of nociceptive neurons in rat medullary dorsal horn.

    J Neurosci. 2007; 27: 9068-9076

    • Coull J.A.
    • Beggs S.
    • Boudreau D.
    • et al.

    BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain.

    Nature. 2005; 438: 1017-1021

  • Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain.

    Brain Behav Immun. 2007; 21: 592-598

  • Targeting astrocyte signaling for chronic pain.

    Neurotherapeutics. 2010; 7: 482-493

    • Guo W.
    • Wang H.
    • Watanabe M.
    • et al.

    Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain.

    J Neurosci. 2007; 27: 6006-60018

    • Hanani M.
    • Huang T.Y.
    • Cherkas P.S.
    • Ledda M.
    • Pannese E.

    Glial cell plasticity in sensory ganglia induced by nerve damage.

    Neuroscience. 2002; 114: 279-283

    • Jasmin L.
    • Vit J.P.
    • Bhargava A.
    • Ohara P.T.

    Can satellite glial cells be therapeutic targets for pain control?.

    Neuron Glia Biol. 2010; 6: 63-71

    • Ji R.R.
    • Kawasaki Y.
    • Zhuang Z.Y.
    • Wen Y.R.
    • Decosterd I.

    Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway.

    Neuron Glia Biol. 2006; 2: 259-269

  • p38 MAPK, microglial signaling, and neuropathic pain.

    Mol Pain. 2007; 3: 33

    • Liu F.Y.
    • Sun Y.N.
    • Wang F.T.
    • et al.

    Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation.

    Brain Res. 2012; 1427: 65-77

    • Meller S.T.
    • Dykstra C.
    • Grzybycki D.
    • Murphy S.
    • Gebhart G.F.

    The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat.

    Neuropharmacology. 1994; 33: 1471-1478

    • Okada-Ogawa A.
    • Suzuki I.
    • Sessle B.J.
    • et al.

    Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms.

    J Neurosci. 2009; 29: 11161-11171

    • Raghavendra V.
    • Tanga F.
    • DeLeo J.A.

    Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy.

    J Pharmacol Exp Ther. 2003; 306: 624-630

  • Interactions between the immune and nervous systems in pain.

    Nat Med. 2010; 16: 1267-1276

    • Svensson C.I.
    • Marsala M.
    • Westerlund A.
    • et al.

    Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing.

    J Neurochem. 2003; 86: 1534-1544

    • Tsuda M.
    • Shigemoto-Mogami Y.
    • Koizumi S.
    • et al.

    P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.

    Nature. 2003; 424: 778-783

    • Watkins L.R.
    • Martin D.
    • Ulrich P.
    • Tracey K.J.
    • Maier S.F.

    Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat.

    Pain. 1997; 71: 225-235

    • Zhang H.
    • Mei X.
    • Zhang P.
    • et al.

    Altered functional properties of satellite glial cells in compressed spinal ganglia.

    Glia. 2009; 57: 1588-1599

    • Zhou Z.
    • Peng X.
    • Hao S.
    • Fink D.J.
    • Mata M.

    HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia.

    Gene Ther. 2008; 15: 183-190

    • Johannes C.B.
    • Le T.K.
    • Zhou X.
    • Johnston J.A.
    • Dworkin R.H.

    The prevalence of chronic pain in United States adults: results of an Internet-based survey.

    J Pain. 2010; 11: 1230-1239

  • Estimates of pain prevalence and severity in adults: United States, 2012.

    J Pain. 2015; 16: 769-780

    • Portenoy R.K.
    • Ugarte C.
    • Fuller I.
    • Haas G.

    Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects.

    J Pain. 2004; 5: 317-328

    • Gureje O.
    • Von Korff M.
    • Simon G.E.
    • Gater R.

    Persistent pain and well-being: a World Health Organization study in primary care.

    JAMA. 1998; 280: 147-151

    • Smith B.H.
    • Elliott A.M.
    • Chambers W.A.
    • Smith W.C.
    • Hannaford P.C.
    • Penny K.

    The impact of chronic pain in the community.

    Fam Pract. 2001; 18: 292-299

    • Rosenblum A.
    • Marsch L.A.
    • Joseph H.
    • Portenoy R.K.

    Opioids and the treatment of chronic pain: controversies, current status, and future directions.

    Exp Clin Psychopharmacol. 2008; 16: 405-416

    • Tunks E.R.
    • Crook J.
    • Weir R.

    Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis.

    Can J Psychiatry. 2008; 53: 224-234

  • Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02.

    Vital Health Stat 13. 2006; : 1-66

    • Volkow N.D.
    • McLellan A.T.

    Opioid abuse in chronic pain: misconceptions and mitigation strategies.

    N Engl J Med. 2016; 374: 1253-1263

  • Fibromyalgia: a clinical review.

    JAMA. 2014; 311: 1547-1555

    • Harper D.E.
    • Schrepf A.
    • Clauw D.J.

    Pain mechanisms and centralized pain in temporomandibular disorders.

    J Dent Res. 2016; 95: 1102-1108

  • Chinese medicine users in the United States, part II: preferred aspects of care.

    J Altern Complement Med. 1998; 4: 189-202

    • Klepser T.B.
    • Doucette W.R.
    • Horton M.R.
    • et al.

    Assessment of patients’ perceptions and beliefs regarding herbal therapies.

    Pharmacotherapy. 2000; 20: 83-87

    • Liu E.H.
    • Turner L.M.
    • Lin S.X.
    • et al.

    Use of alternative medicine by patients undergoing cardiac surgery.

    J Thorac Cardiovasc Surg. 2000; 120: 335-341

    • DeBar L.L.
    • Vuckovic N.
    • Schneider J.
    • Ritenbaugh C.

    Use of complementary and alternative medicine for temporomandibular disorders.

    J Orofac Pain. 2003; 17: 224-236

    • Younger J.
    • Noor N.
    • McCue R.
    • Mackey S.

    Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.

    Arthritis Rheum. 2013; 65: 529-538

  • Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

    Pain Med. 2009; 10: 663-672

    • Oaks Z.
    • Stage A.
    • Middleton B.
    • Faraone S.
    • Johnson B.

    Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.

    Discov Med. 2018; 26: 197-206

  • Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia.

    Biomedicines. 2017; 5: 16

    • Ramanathan S.
    • Panksepp J.
    • Johnson B.

    Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?.

    Psychosomatics. 2012; 53: 591-594

    • Rivera V.
    • DeCicco J.
    • Espirit S.

    Proceedings #47: low dose naltrexone: a viable alternative for long term chronic pain?.

    Brain Stimul. 2019; 12: e118-e120

  • Low-dose naltrexone: a new therapy option for complex regional pain syndrome type I patients.

    Int J Pharm Compound. 2016; 20: 197-201



  • Source link

    Related Articles

    Leave a Comment